Companies move to Veeva Vault EDC for greater speed and efficiency SINGAPORE, Feb. 27, 2023 /PRNewswire/ Veeva Systems (NYSE: VEEV) today announced increasing adoption of Veeva Vault EDC as leading organizations - including 6 of the top 20 pharma - move to modernize clinical data management. Benefitting from Vault EDC's advanced data capabilities to streamline study build and data processing, companies can achieve significant savings in time, effort, and cost and provide a better research site experience. With increasing trial complexity, biopharmaceutical companies need agile systems that allow clinical teams to design, start, execute, and amend all types of studies quickly. Vault EDC delivers dynamic design tools that automate manual processes and enable faster study builds. As the trial progresses, Vault EDC users can make amendments without costly data migrations. "The industry is making significant progress in its move to patient-centric trials," said Richard Young
/PRNewswire/ Veeva Systems (NYSE: VEEV) today announced increasing adoption of Veeva Vault EDC as leading organizations – including 6 of the top 20 pharma –.
Companies move to Veeva Vault EDC for greater speed and efficiency BARCELONA, Spain, Feb. 23, 2023 /PRNewswire/ Veeva Systems (NYSE: VEEV) today announced increasing adoption of Veeva
/PRNewswire/ - Platform Life Sciences, a high impact Clinical Research Organization, with the mission to modernize clinical trials on a global scale, has.
Effect of early treatment with fluvoxamine on risk of emergency care and hospitalisation among patients with COVID-19: the TOGETHER randomised, platform clinical trial thelancet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thelancet.com Daily Mail and Mail on Sunday newspapers.